IP Library Granted Patent US 12,343,315
Granted Patent B2
US 12,343,315 · App. 17/075,764 · Granted Jul 1, 2025

Topical cannabinoid compositions for clear skin

Inventors: Frantz Henri Emmanuel Le Devedec (North York, CA); Akm Abdul Hai (Etobicoke, CA); Aras Azadian (Toronto, CA); Setu Nimish Purohit (Toronto, CA); Justin Michael Grant (Toronto, CA); Samantha Carolyn Watt (Toronto, CA)
Assignee: Avicanna Inc.
A61K31/05A61K8/042A61K8/347A61K8/9789A61K9/06A61K31/015A61K36/53A61K36/61A61P17/10A61Q19/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,343,315
App. No.
17/075,764
Granted
Jul 1, 2025
Kind
B2
Abstract

Topical composition comprising cannabinoids in combination with one or more antioxidants, one or more anti-microbial agents, one or more anti-inflammatory agents and one or more skin conditioning agents are provided. Also provided are methods comprising applying a topical composition provided herein to the skin of a subject and uses of a topical composition for promoting hydration and clear skin.

Claims (31)

1. A topical cannabinoid homogenous gel emulsion composition comprising

a cannabinoid at 0.1-10% (w/w),

an antioxidant at 0.01-5% (w/w),

an anti-microbial agent at 0.01-2% (w/w),

an anti-inflammatory agent at 0.01-5% (w/w) and

a skin conditioning agent at 0.01-5% (w/w),

wherein the topical cannabinoid homogenous gel emulsion composition comprises less than 20% (w/w) of simple polyol,

wherein the cannabinoid is cannabidiol (CBD),

wherein the anti-inflammatory agent is beta-caryophyllene, and

wherein the topical cannabinoid homogenous gel emulsion composition further comprises a humectant at 1-10% (w/w),

a thickening agent at 0.01-10% (w/w),

a gel-forming agent at 0.1-5% (w/w),

a preservative at 0.1-3% (w/w),

an emollient at 1-3% (w/w),

a non-ionic surfactant at 1-15% (w/w),

a penetration enhancer at 1-5% (w/w),

a fragrance agent at 0.01-2% (w/w),

a pH adjusting agent in a quantity sufficient for the topical cannabinoid homogenous gel emulsion composition to maintain pH 5-7, and

water to make up 100% by weight,

wherein the gel-forming agent is carbomer,

wherein the emollient is isopropyl myristate, and

wherein the penetration enhancer is diethylene glycol monoethyl ether.

2. The topical cannabinoid composition of claim 1 , wherein the topical cannabinoid homogenous gel emulsion composition comprises no more than 2% (w/w) of simple polyol.

3. The topical cannabinoid homogenous gel emulsion composition of claim 1 , wherein the antioxidant and anti-microbial agent are essential anise oil, angelica oil, basil oil, bay oil, bergamot oil, rose oil, camphor oil, cardamom oil, caraway oil, cedar oil, cedarwood oil, chamomile oil, cinnamon oil, citronella oil, clove oil, copaiba balsam oil, cumin oil, coriander oil, dill oil, eucalyptus oil, fennel oil, garlic oil, geranium oil, grapefruit oil, ginger oil, guaiac oil, iris oil, Japanese mint oil, jasmine oil, lavender oil, lemon oil, lemongrass oil, lindera oil, mandarin oil, mint oil, neroli oil, onion oil, orange oil, oregano oil, patchouli oil, parsley oil, pepper oil, peppermint oil, perilla oil, Peru balsam oil, petitgrain oil, pine oil, pine needle oil, rose oil, rosemary oil, sandalwood oil, spearmint oil, star anis oil, sweet orange oil, tangerine oil, tea seed oil, tea tree oil, thyme oil, tolu balsam oil, tuberose oil, turmeric oil, western mint oil, wintergreen oil, combinations, and mixtures thereof.

4. The topical cannabinoid homogenous gel emulsion composition of claim 3 , wherein the antioxidant is rosemary oil.

5. The topical cannabinoid homogenous gel emulsion composition of claim 3 , wherein the anti-microbial agent is tea tree oil.

6. The topical cannabinoid homogenous gel emulsion composition of claim 1 , wherein the skin conditioning agent is avocado oil, canola oil, coconut oil, corn oil, cotton seed oil, flax seed oil, grape seed oil, hemp seed oil, olive oil, palm oil, peanut oil, safflower oil, soybean oil, combinations, and mixtures thereof.

7. The topical cannabinoid homogenous gel emulsion composition of claim 6 , wherein the skin conditioning agent is hemp seed oil.

8. The topical cannabinoid homogenous gel emulsion composition of claim 1 , wherein the humectant is glycerin, the thickening agent is xanthan gum, the preservative is phenoxyethanol, the non-ionic surfactant is polysorbate 80, the fragrance agent is peppermint essential oil, and the pH adjusting agent is sodium hydroxide.

9. The homogenous gel emulsion of claim 1 , wherein the composition has a viscosity in a range of about 5,000 to about 100,000 cps.

10. A method comprising applying the topical cannabinoid homogenous gel emulsion composition of claim 1 to the skin of a subject, wherein the skin of the subject is affected by acne vulgaris.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2020
From: LE DEVEDEC, FRANTZ HENRI EMMANUEL; HAI, AKM ABDUL; AZADIAN, ARAS; PUROHIT, SETU NIMISH; GRANT, JUSTIN MICHAEL; WATT, SAMANTHA CAROLYN
To: AVICANNA INC.
Reel/Frame 054271/0687 →
Continuity (2)
Provisional Application 62923905 · Oct 21, 2019
Related Publication 20210113490A1 · Apr 22, 2021
References Cited (22)
US 9730911B2 · Verzura et al. · 2017 [cited by applicant]
US 10555928B2 · Blackmon et al. · 2020 [cited by applicant]
US 20160106705A1 · Verzura et al. · 2016 [cited by applicant]
US 20170360745A1 · Blackmon et al. · 2017 [cited by applicant]
US 20190247325A1 · Kleidon · 2019 [cited by applicant]
US 20190275095A1 · Spencer et al. · 2019 [cited by applicant]
US 20190307719A1 · Karelis et al. · 2019 [cited by applicant]
US 20190374552A1 · Hoag · 2019 [cited by applicant]
US 20200215026A1 · Blackmon et al. · 2020 [cited by applicant]
US 20200253921A1 · May et al. · 2020 [cited by applicant]
US 20200327987A1 · May et al. · 2020 [cited by applicant]
US 20210046040A1 · Avram · 2021 [cited by applicant]
WO 2017218853 · 2017 [cited by applicant]
WO 2018023164 · 2018 [cited by applicant]
WO WO2018023164A1 · 2018 [cited by examiner]
WO 2018085535 · 2018 [cited by applicant]
WO WO2018085535A2 · 2018 [cited by examiner]
WO 2019089583 · 2019 [cited by applicant]
WO WO2019089583A1 · 2019 [cited by examiner]
WO 2019195943 · 2019 [cited by applicant]
WO 2020012480 · 2020 [cited by applicant]
PCT International Application No. PCT/IB20/060668, International Search Report and Written Opinion of the International Searching Authority, dated Jul. 15, 2021, 12 pages. [cited by applicant]